Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


compulsive behaviour

Special reports

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

READ MORE
QUOTES-ORANGE

Perspectives

Who said what: QoTW 11.06.15

Our favourite quotes of the week from around the web

READ MORE
Avocado pear

Recipes & Nutrition

Naturally good food: the diets proven to boost the body against Parkinson’s

Diets from around the world that help Parkinson’s symptoms

READ MORE